Advertisement
Screener

ARS Pharmaceuticals, Inc. (SPRY) ROA

ARS Pharmaceuticals, Inc. (SPRY) ROA

  • 2026-06-30: ROA -86.35%.
  • 2026-03-31: ROA -68.84%.
  • 2025-12-31: ROA -52.28%.
  • 2025-09-30: ROA -21.47%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-86.35%
2026-03-31-68.84%
2025-12-31-52.28%
2025-09-30-21.47%
2025-06-30-15.32%
2025-03-31-4.78%
2024-12-312.28%
2024-09-30-22.57%
2024-06-30-20.20%
2024-03-31-21.84%
2023-12-31-23.31%
2023-09-30-24.79%
2023-06-30-20.62%
2023-03-31-15.63%
2022-12-31-12.32%
2022-09-309.42%
2022-06-303.21%
2022-03-31-2.76%
2021-12-31-32.94%
2021-09-30-22.44%
2021-06-30-17.59%
2021-03-31-12.18%
2020-12-31-8.35%

Annual ROA

DateROA
2025-12-31-52.28%
2024-12-312.28%
2023-12-31-23.31%
2022-12-31-12.32%
2021-12-31-32.94%
2020-12-31-8.35%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85